Dosidal · Switzerland

Bimatoprost-Mepha Plus, Augentropfenlösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:66976 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 66976
atc: S01ED51
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2018-10-03
term: zugelassen
valid_until: 2027-01-01
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: S01ED51
authorisation_number: 66976
form: AUGT
holder: Mepha Pharma AG
holder_partner_nr: 1006155
it_number: 11.09.0.
name: Bimatoprost-Mepha Plus, Augentropfenlösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
GzPBKBAVxAU0-6V0OYqHZmvj7DMzovDAWpLHSuso6mk86lhwMF3kgYVFxCcYwo_NIm8DfYYwb1W_tzgLtnpqaQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:66976 · Related records in other markets · Dosidal